000 01617nam  2200373zi 4500
0019.883393
003CaOODSP
00520231208121424
006m     o  d f      
007cr cn|||||||||
008200109t20202020onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-27/2020-01E-PDF|zH113-27/2020-01E
24500|aFenhexamid and its associated end-use products : |bconsultation document.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2020.
264 4|c©2020
300 |a1 online resource (82 pages).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aProposed re-evaluation decision, |x1925-0967 ; |vPRVD2020-01
500 |aIssued also in French under title: Fenhexamide et préparations commerciales connexes : document de consultation.
500 |aCover title.
500 |a"7 January 2020."
504 |aIncludes bibliographical references.
650 0|aFungicides|xCertification|zCanada.
650 0|aFungicides|xToxicology.
650 0|aFungicides|xEnvironmental aspects.
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tFenhexamide et préparations commerciales connexes : |w(CaOODSP)9.883396
830#0|aProposed re-evaluation decision (Canada. Pest Management Regulatory Agency)|vPRVD2020-01.|w(CaOODSP)9.505201
85640|qPDF|s716 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/h113-27/H113-27-2020-01-eng.pdf|z(report)